[The effect of cefmetazole in the treatment of acute prostatitis and acute epididymitis].
Cefmetazole (CMZ) was intravenously injected to 12 patients with acute prostatitis as well as 3 patients with acute epididymitis. Good clinical results were obtained in 10 patients (91.7%) with acute prostatitis and 2 patients (100%) with acute epididymitis. No side effects were reported in all of 23 patients. Thus, CMZ could be expected to reveal good response in the treatment of male genital infections.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D015311:Cefmetazole; D002511:Cephalosporins / Q000627:therapeutic use*; D002513:Cephamycins / Q000627:therapeutic use*; D004823:Epididymitis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011472:Prostatitis / Q000188:drug therapy*
D002511:Cephalosporins; D002513:Cephamycins; D015311:Cefmetazole